The content on this site is intended for healthcare professionals only
Dr Rita Lawlor speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the use of biobanking and cancer models for applied cancer research.
She states that cancer research relies heavily on using tissue - which is a limited resource.
Dr Lawlor explains the use of patient-derived xenograft models as a method to obtain more tissue and the challenges that surround this.
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
TROP2 expression measured by QCS is a promising predictor of clinical outcomes in patients with mNSCLC
EHA 2024: Multiple myeloma roundup
Whole body-MRI and fluorine 18 fluorodeoxyglucose PET/CT shows promising diagnostic accuracy in multiple myeloma patients
Synthetic biology and precision medicine in blood and gynaecological cancers
Innovative treatments for solid tumours – TTFields as a therapeutic modality
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
